Stem Cell Therapy Market - Global Industry Analysis

Stem Cell Therapy Market- By Cell Source (Adipose Tissue-Derived Mesenchymal SCs, Bone Marrow-Derived Mesenchymal SCs, and Embryonic SCs), By Type (Allogenic SCs And Autologous SCs), By End-User (ASCs And Hospitals), And By Therapeutic Application (Musculoskeletal Disorders, Wounds & Injuries, Cardiovascular Diseases, Gastrointestinal Diseases, and Immune System Diseases): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021–2028

Published Date: 14-Dec-2021 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-2341 Status : Published

The global Stem Cell Therapy Market accrued earnings worth approximately 182 (USD Million) in 2020 and is predicted to gain revenue of about 800 (USD Million) by 2028, is set to record a CAGR of nearly 20.1% over the period from 2021 to 2028.

Description

Stem Cell Therapy Market Size

The global Stem Cell Therapy Market accrued earnings worth approximately 182 (USD Million) in 2020 and is predicted to gain revenue of about 800 (USD Million) by 2028, is set to record a CAGR of nearly 20.1% over the period from 2021 to 2028. The report offers assessment and analysis of the Stem Cell Therapy Market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Million).

Stem Cell Therapy Market: Outlook

Stem cells possess the ability to build each tissue in the human body and possess huge potential for future therapeutic use in the regeneration & repair of tissues. Moreover, stem cells are capable of self-replication while retaining the features of a parent or host cells. In addition to this, stem cells have been intensely studied for understanding organogenesis & human growth. Due to breakthroughs in stem cell therapies, the regenerative medicine industry has witnessed massive growth. Reportedly, ophthalmic conditions, which are a major cause of blindness across the globe, are treated with stem cell therapy. Apparently, favorable outcomes have been derived while treating maxillofacial and oral deficiencies through stem cell therapy. For the record, latter possesses huge potential for treating diabetes and cardiomyopathy.  Nevertheless, an exceptional feature of stem cells in migrating towards cancer cells has proved them to be key (vectors) in transporting bioactive agents as well as targeting cancer tissues.

Global Stem Cell Therapy Market

Stem Cell Therapy Market: Growth Drivers

Preclinical and medical research activities have brought enormous improvements in stem cell treatments and the latter is the best option having a high potential for treating various kinds of diseases in which current medical therapies have failed to cure, prevent disease development, and alleviate disease symptoms. This aspect is likely to offer new growth opportunities for the stem cell therapy market. Moreover, stem cells can be used as replacement cells during human organ transplantation and can be useful in treating a slew of diseases.

Stem cell therapy also finds a plethora of applications in dermatology with the former having the ability of healing wounds. It can also enable the regeneration of damaged skin tissues. This is likely to drive market trends.  Furthermore, a wide variety of possibilities & potential of stem cell therapy has made it a cutting-edge therapy. Stem cell therapy has helped modern medicine enter a new era of growth while providing hope for patients suffering from chronic & incurable diseases. All these aforementioned aspects will help the stem cell therapy market explore new facades of growth in the coming decade.

Furthermore, the use of stem cell therapy in treating metabolic disorders, eye problems, musculoskeletal diseases, heart disorders, and central nervous system ailments will embellish the industry landscape. The rise in the funding of research activities pertaining to stem cell treatment will promulgate industry growth.  However, high costs and ethical concerns about the origin of stem cells can lessen the implementation of stem cell therapy on large scale, thereby hindering the expansion of the stem cell therapy market.

Stem Cell Therapy Market: Regional Landscape

North America To Account Sizably Towards Overall Market Share By 2028

The growth of the stem cell therapy market in North America over the anticipated timeline is subject to rising in clinical research pertaining to stem cell therapy in countries such as the U.S. In addition to this, the rise in chronic diseases and government aid facilitating the use of stem cell treatment for these severe disorders will enlarge the scope of the market in the region. Apart from this, thriving biotechnology sector and massive research in whole genome synthesis domain and genome sequencing field will protrude expansion of the stem cell therapy market in sub-continent.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Stem Cell Therapy Market: Competitive Landscape

Key players influencing growth of stem cell therapy market and profiled in report include MEDIPOST Co., Ltd., JCR Pharmaceuticals Co., Ltd., Anterogen Co., Ltd., NuVasive, Inc., RTI Surgical, Inc., Pharmicell Co., Ltd., Holostem Terapie Avanzate S.r.l., and AlloSource.

The global Stem Cell Therapy Market is segmented as follows:

By Cell Source

  • Adipose Tissue-Derived Mesenchymal SCs
  • Bone Marrow-Derived Mesenchymal SCs
  • Embryonic SCs

By Type

  • Allogenic SCs
  • Autologous SCs

By End-User

  • ASCs
  • Hospitals

By Therapeutic Application

  • Musculoskeletal Disorders
  • Wounds & Injuries
  • Cardiovascular Diseases
  • Gastrointestinal Diseases
  • Immune System Diseases

By Region

  • North America

    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Stem Cell Therapy Market, 2018–2028(USD Million)
    • 2.2. Stem Cell Therapy Market: Snapshot
  • Chapter 3. Global Stem Cell Therapy Market– Industry Analysis
    • 3.1. Stem Cell Therapy Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Humungous utilization of stem cell therapy in treating metabulic disorders, eye ailments, musculoskeletal diseases, heart disorders, and central nervous system issues will prop up market size.
      • 3.2.2. Surge in government & private funding of research works associated with stem cell treatment projects will pruliferate industry expansion.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Therapeutic Application
      • 3.4.2. Market attractiveness analysis By Type
      • 3.4.3. Market attractiveness analysis By Cell Source
      • 3.4.4. Market attractiveness analysis By End-User
  • Chapter 4. Global Stem Cell Therapy Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Stem Cell Therapy Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Stem Cell Therapy Market– Cell Source Analysis
    • 5.1. Global Stem Cell Therapy Market overview: By Cell Source
      • 5.1.1. Global Stem Cell Therapy Market share, By Cell Source, 2020 and 2028
    • 5.2. Adipose Tissue-Derived Mesenchymal SCs
      • 5.2.1. Global Stem Cell Therapy Marketby Adipose Tissue-Derived Mesenchymal SCs, 2018–2028(USD Million)
    • 5.3. Bone Marrow-Derived Mesenchymal SCs
      • 5.3.1. Global Stem Cell Therapy Marketby Bone Marrow-Derived Mesenchymal SCs, 2018–2028(USD Million)
    • 5.4. Embryonic SCs
      • 5.4.1. Global Stem Cell Therapy Marketby Embryonic SCs, 2018–2028(USD Million)
  • Chapter 6. Global Stem Cell Therapy Marketoverview: By Type
    • 6.1. Global Stem Cell Therapy Marketshare, By Type , 2020 and 2028
    • 6.2. Allogenic SCs
      • 6.2.1. Global Stem Cell Therapy Marketby Allogenic SCs, 2018–2028(USD Million)
    • 6.3. Autulogous SCs
      • 6.3.1. Global Stem Cell Therapy Marketby Autulogous SCs, 2018–2028(USD Million)
  • Chapter 7. Global Stem Cell Therapy Marketoverview: By End-User
    • 7.1. Global Stem Cell Therapy Marketshare, By End-User , 2020 and 2028
    • 7.2. ASCs
      • 7.2.1. Global Stem Cell Therapy Marketby ASCs, 2018–2028(USD Million)
    • 7.3. Hospitals
      • 7.3.1. Global Stem Cell Therapy Marketby Hospitals, 2018–2028(USD Million)
  • Chapter 8. Global Stem Cell Therapy Marketoverview: By Therapeutic Application
    • 8.1. Global Stem Cell Therapy Marketshare, By Therapeutic Application , 2020 and 2028
    • 8.2. Musculoskeletal Disorders
      • 8.2.1. Global Stem Cell Therapy Marketby Musculoskeletal Disorders, 2018–2028(USD Million)
    • 8.3. Wounds & Injuries
      • 8.3.1. Global Stem Cell Therapy Marketby Wounds & Injuries, 2018–2028(USD Million)
    • 8.4. Cardiovascular Diseases
      • 8.4.1. Global Stem Cell Therapy Marketby Cardiovascular Diseases, 2018–2028(USD Million)
    • 8.5. Gastrointestinal Diseases
      • 8.5.1. Global Stem Cell Therapy Marketby Gastrointestinal Diseases, 2018–2028(USD Million)
    • 8.6. Immune System Diseases
      • 8.6.1. Global Stem Cell Therapy Marketby Immune System Diseases, 2018–2028(USD Million)
  • Chapter 9. Company Profiles
    • 9.1. MEDIPOST Co., Ltd.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfulio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. JCR Pharmaceuticals Co., Ltd.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfulio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Anterogen Co., Ltd.
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfulio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Development
    • 9.4. NuVasive, Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfulio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Development
    • 9.5. RTI Surgical, Inc.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfulio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. Pharmicell Co., Ltd.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfulio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. Hulostem Terapie Avanzate S.r.l.
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfulio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development
    • 9.8. AlloSource
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfulio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Stem Cell Therapy Market, 2018–2028(USD Million)
4. Porter’s Five Forces Analysis
5. Global Stem Cell Therapy Marketattractiveness, By Therapeutic Application
6. Global Stem Cell Therapy Marketattractiveness, By Type
7. Global Stem Cell Therapy Marketattractiveness, By Cell Source
8. Global Stem Cell Therapy Marketattractiveness, By End-User
9. Global Stem Cell Therapy Marketshare by Cell Source ,2020 and 2028 (USD Million)
10. Global Stem Cell Therapy Marketby Adipose Tissue-Derived Mesenchymal SCs, 2018–2028(USD Million)
11. Global Stem Cell Therapy Marketby Bone Marrow-Derived Mesenchymal SCs, 2018–2028(USD Million)
12. Global Stem Cell Therapy Marketby Embryonic SCs, 2018–2028(USD Million)
13. Global Stem Cell Therapy Marketshare by Type ,2020 and 2028 (USD Million)
14. Global Stem Cell Therapy Marketby Allogenic SCs, 2018–2028(USD Million)
15. Global Stem Cell Therapy Marketby Autologous SCs, 2018–2028(USD Million)
16. Global Stem Cell Therapy Marketshare by Therapeutic Application ,2020 and 2028 (USD Million)
17. Global Stem Cell Therapy Marketby Musculoskeletal Disorders, 2018–2028(USD Million)
18. Global Stem Cell Therapy Marketby Wounds & Injuries, 2018–2028(USD Million)
19. Global Stem Cell Therapy Marketby Cardiovascular Diseases, 2018–2028(USD Million)
20. Global Stem Cell Therapy Marketby Gastrointestinal Diseases, 2018–2028(USD Million)
21. Global Stem Cell Therapy Marketby Immune System Diseases, 2018–2028(USD Million)
22. Global Stem Cell Therapy Marketshare by End-User ,2020 and 2028 (USD Million)
23. Global Stem Cell Therapy Marketby ASCS, 2018–2028(USD Million)
24. Global Stem Cell Therapy Marketby Hospitals,  2018–2028(USD Million)
25. Global Stem Cell Therapy Marketshare, by Region, 2020 and 2028
26. North America Stem Cell Therapy Market, 2018–2028(USD Million)
27. Europe Stem Cell Therapy Market, 2018–2028(USD Million)
28. Asia Pacific Stem Cell Therapy Market, 2018–2028(USD Million)
29. Latin America Stem Cell Therapy Market, 2018–2028(USD Million)
30. The Middle East and Africa Stem Cell Therapy Market, 2018–2028(USD Million)


Table Of Tables

List of Tables

1. Global Stem Cell Therapy Market: snapshot
2. Drivers of the Stem Cell Therapy Market: impact analysis
3. North America Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
4. North America Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
5. North America Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
6. North America Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
7. The U.S. Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
8. The U.S. Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
9. The U.S. Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
10. The U.S. Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
11. Rest of North America Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
12. Rest of North America Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
13. Rest of North America Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
14. Rest of North America Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
15. Europe Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
16. Europe Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
17. Europe Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
18. Europe Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
19. UK Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
20. UK Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
21. UK Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
22. UK Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
23. France Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
24. France Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
25. France Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
26. France Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
27. Germany Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
28. Germany Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
29. Germany Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
30. Germany Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
31. Rest of Europe Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
32. Rest of Europe Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
33. Rest of Europe Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
34. Rest of Europe Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
35. Asia Pacific Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
36. Asia Pacific Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
37. Asia Pacific Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
38. Asia Pacific Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
39. China Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
40. China Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
41. China Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
42. China Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
43. Japan Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
44. Japan Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
45. Japan Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
46. Japan Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
47. India Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
48. India Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
49. India Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
50. India Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
51. Rest of Asia Pacific Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
52. Rest of Asia Pacific Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
53. Rest of Asia Pacific Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
54. Rest of Asia Pacific Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
55. Latin America Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
56. Latin America Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
57. Latin America Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
58. Latin America Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
59. Brazil Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
60. Brazil Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
61. Brazil Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
62. Brazil Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
63. Rest of Latin America Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
64. Rest of Latin  America Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
65. Rest of Latin America Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
66. Rest of Latin America Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
67. The Middle East and Africa Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
68. The Middle East and Africa Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
69. The Middle East and Africa Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
70. The Middle East and Africa Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
71. Saudi Arabia Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
72. Saudi Arabia Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
73. Saudi Arabia Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
74. Saudi Arabia Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
75. South Africa Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
76. South Africa Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
77. South Africa Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
78. South Africa Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
79. Rest of the Middle East & Africa Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
80. Rest of the Middle East & Africa Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
81. Rest of the Middle East & Africa Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
82. Rest of the Middle East & Africa Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)


 

Methodology

Free Analysis

Stem cell therapy is a type of treatment in which a range of injuries, diseases & other health conditions are treated with the help of stem cells. Stem cells are the undifferentiated cells of the body which have a remarkable potential to divide themselves into any kind of cell. When a stem cell undergoes division, the new cell formed is either a new stem cell or another cell which have a specific function.

Increase in funding by government organizations & various other institutions for innovating & developing new stem cell therapy & products is mainly fueling the growth of the global market. In addition, increase in the prevalence of chronic diseases and disorders, the rise in awareness about the use of stem cell therapy to treat these diseases and disorders, and increase in the approval of stem cell research clinical trials are also anticipated to fuel the growth of global stem cell therapy market. Rapid development in the infrastructure for stem cell processing & banking is expected to increase the growth of the market of stem cell therapy.

Global Stem Cell Therapy Market

Stem cells therapy market is segmented on the basis of type, therapeutic application, cell source, and end user. On the basis of type, stem cell therapy market is segmented into autologous stem cells & allogenic stem cells. Therapeutic application segment includes musculoskeletal disorders, immune system diseases, gastrointestinal diseases, cardiovascular diseases, wounds & injuries, and others. Cardiovascular disease segment is expected to dominate the market in the forecast period. Based on cell source, the market is segmented into adipose tissue-derived mesenchymal SCs, embryonic SCs, bone-marrow derived mesenchymal SCs, and others. Embryonic SCs dominate the market as it is easy to obtain as compared to the adult stem cells. On the basis of the end user, the stem cell therapy market is segmented ASCs & hospital. The hospital segment is expected to dominate the stem cell therapy market in the forecast period.

North America is projected to dominate the stem cell therapy market in the forecast period. This is due to the rapid growth in awareness about the stem cell therapy & adoption of these stem cell therapies for the treatment of various diseases & conditions. The Asia Pacific is projected to show the highest growth rate in the forecast period due to rising investments by the government & other funding agencies for the scientific research & development of new innovative stem cells products & therapies. Also, adoption of western lifestyle & increase in healthcare expenditure is expected to fuel the growth of the market in the Asia Pacific region.

The main players involved in the global stem cell therapy market are Anterogen Co., Ltd., RTI Surgical, Inc., Pharmicell Co., Ltd., MEDIPOST Co., Ltd., JCR Pharmaceuticals Co., Ltd., Holostem Terapie Avanzate S.r.l., NuVasive, Inc., and AlloSource. The companies are involved in introducing new & innovative product approvals & launches for their growth.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

Preclinical and medical research activities have brought enormous improvements in stem cell treatments and the latter is a best option having high potential for treating various kinds of diseases in which current medical therapies have failed to cure, prevent disease development, and alleviate disease symptoms. This aspect is likely to offer new growth opportunities for stem cell therapy market. Moreover, stem cells can be used as replacement cells during human organ transplantation and can be useful in treating      a slew of diseases. Stem cell therapy also finds plethora of applications in dermatology with former having ability of healing wounds. It can also enable regeneration of damaged skin tissues. This is likely to drive market trends.  Furthermore, a wide variety of possibilities & potential of stem cell therapy has made it a cutting edge therapy. Stem cell therapy has helped modern medicine enter a new era of growth while providing a hope for patients suffering from chronic & incurable diseases. All these aforementioned aspects will help stem cell therapy market explore new facades of growth in coming decade.

      

According to Zion market research report, The global Stem Cell Therapy Market accrued earnings worth approximately 182 (USD Million) in 2020 and is predicted to gain revenue of about 800 (USD Million) by 2028, is set to record a CAGR of nearly 20.1% over the period from 2021 to 2028.

North America will contribute lucratively towards the global market earnings over the projected timeline. The regional market surge is subject to rise in clinical research pertaining to stem cell therapy in countries such as the U.S. In addition to this, rise in chronic diseases and government aid facilitating use of stem cell treatment for these severe disorders will enlarge scope of market in region. Apart from this, thriving biotechnology sector and massive research in whole genome synthesis domain and genome sequencing field will protrude expansion of stem cell therapy market in sub-continent.

The key market participants include MEDIPOST Co., Ltd., JCR Pharmaceuticals Co., Ltd., Anterogen Co., Ltd., NuVasive, Inc., RTI Surgical, Inc., Pharmicell Co., Ltd., Holostem Terapie Avanzate S.r.l., and AlloSource. 

 

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed